Approvals/TGA/BTC CANDESARTAN HCT candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack

Approved

STANDARD

BTC CANDESARTAN HCT candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: befcf090421be6c7
Product Name: BTC CANDESARTAN HCT candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack
Artg Id: 396084
Artg Name: BTC CANDESARTAN HCT candesartan cilexetil/hydrochlorothiazide 16 mg/12.5 mg tablet blister pack
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2022-12-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02187-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-02472-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

befcf090421be6c7

Type

Standard